Please assess the completion status of the following clinical trial:

Trial Title: The Effects of Fish Oil Supplements During Supervised Exercise Therapy in Patients With Intermittent Claudication

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 18~* Newly diagnosed intermittent claudication~* Ankle Brachial Index \< 0.8 at rest or \> 0.15 decrease after exercise~* Able to perform standardised treadmill walking test for 2 min~* Written informed consent~Exclusion Criteria:~* Unable to fill out a questionnaire (cognitive impairment or insufficient knowledge of the Dutch language)~* Heart failure or unstable cardiac status (angina pectoris class III or IV or recent myocardial infarction \< 3 months)~* Any illness with rapid evolution or a life expectancy \< 3 months~* Recent cerebrovascular accident (\< 3 months)~* Current use of fish oil supplements or \> 2 times a week dietary fish~* Pregnancy~* Fish, soybean or peanut allergy~* Contra indications for the use of omega-3 fatty acids~* Use of oral anticoagulants (coumarin derivatives)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Supervised Exercise Therapy (Type: ACTIVE_COMPARATOR): Standard treatment: Supervised Exercise Therapy during 12 weeks
- Controlled group (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).